# Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula

> **NCT01863914** · PHASE2 · COMPLETED · sponsor: **National Cheng-Kung University Hospital** · enrollment: 60 (actual)

## Conditions studied

- End-stage Kidney Disease
- Diabetes Mellitus
- Arteriovenous Fistula

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT01863914
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-01-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01863914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01863914, "Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01863914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*